Qi Qi1,2,3, Matthew Fox1,4, Robert Bartha2,5,6, Miranda Bellyou5, Lise Desjardins7, Lisa Hoffman1,2,8, Alex Li5, Andrew McClennan1,2, Ting Yim Lee1,2,3,5,6, and Jonathan D Thiessen1,2,3,6
1Lawson Imaging, Lawson Health Research Institute, London, ON, Canada, 2Medical Biophysics, Western University, London, ON, Canada, 3Molecular Imaging, Western University, London, ON, Canada, 4Physics and Astronomy, Western University, London, ON, Canada, 5Robart Research Institute, London, ON, Canada, 6Medical Imaging, Western University, London, ON, Canada, 7Lawson Health Research Institute, London, ON, Canada, 8Anatomy and Cell Biology, Western University, London, ON, Canada
Synopsis
There is an intrinsic relationship between
tumour glycolysis and its pH environment. CEST MRI enables the detection of
tumour pH in both intra- (pHi) and extracellular (pHe)
spaces with AACID and acidoCEST methods. Kinetic analysis of dynamic FDG-PET can
provide an accurate measurement of tumour glycolysis. This study demonstrates
the capability of simultaneous measurements of pHi and pHe
using CEST MRI, providing a more complete picture of the tumour pH environment,
and explores the intrinsic relationship between tumour glycolysis and its pH
environment.
Introduction
Glioblastoma is one of the most aggressive brain
tumours and patients diagnosed with glioma have a median survival time of 12-15
months [1]. One of the hallmarks of glioma is the reliance on glycolytic
metabolism, even with adequate oxygen supply [2]. A large amount of lactate
acid and H+ protons are produced from glycolysis, resulting in a
more acidic tumour environment. Injection of glucose could lead to a drop in
tumour pH environment due to the reliance on glycolysis [3]. There is an
intrinsic relationship between tumour glycolysis and its pH environment. Chemical
exchange saturation transfer (CEST) MRI is sensitive to pH and can be used in vivo to detect intracellular pH (pHi) with amine and amide
concentration independent detection (AACID) [4], and extracellular (pHe) with
acidoCEST using iopamidol (Isovue) [5]. Glucose metabolism can be evaluated using
kinetic modeling of dynamic positron emission tomography (PET) data obtained
from 18F-fluorodeoxyglucose (FDG), a glucose analogue which is
phosphorylated in the cell but does not go through the subsequent steps of
glycolysis. In this study, we compared CEST measurements of AACID and acidoCEST
to FDG-PET to explore
the relationship between the tumour pH environment and glycolytic metabolism. Methods
All
animal experiments followed approved local animal ethics protocols. 106
C6 glioma cells were implanted in the brains of Wistar rats (n=11) using
stereotactic surgery. Tumours were monitored actively using MRI (Siemens
Biograph mMR) starting from Day 7 after the surgery. Tumour and peri-tumour glucose
metabolism were represented by the Patlak influx constant (Ki) derived
from PET kinetic analysis (as shown in Figure 1) of dynamic PET data (Siemens
Inveon) acquired for 90 minutes after a bolus of FDG (30 ± 2 MBq) 11 days
post-surgery. CEST measurements were acquired the
following day. A 60-minute constant infusion of 300 mgI/ml of Isovue was
started prior to CEST acquisition at a dose of 0.75 gI/kg. CEST spectra were
acquired on a 9.4 T Bruker MRI using a continuous wave presaturation pulse preceding
a series of echo-planar images. One CEST spectra was acquired pre-glucose
infusion followed by a second CEST spectra acquired after a bolus of glucose
solution (0.3 g/kg). The effect of glucose infusion on tumour and peri-tumour pHi
were evaluated using amine and amide concentration-independent detection
(AACID). AACID maps were generated by using the ratio between the CEST signal for
the amine proton at 3.5 ppm and the amide proton at 2.75 ppm pre- and post-glucose
injection. ∆AACID was calculated as the difference in AACID value between post-
and pre-glucose injection. The effect of glucose infusion on tumour and
peri-tumour pHe were evaluated using acidoCEST. Maps of acidoCEST
were derived using the ratio between CEST signal of two amide protons on
Iopamidol at 4.2 and 5.6 ppm pre- and post-glucose injection. ∆acidoCEST was
calculated as the difference in acidoCEST value between post- and pre-glucose
injection. The correlations between PET measurements of Ki and CEST
measurements of AACID and acidoCEST were evaluated using Pearson’s correlation.
Results
An
increase in average tumour and peri-tumour AACID values (Figure 2a and 2b);
and a decrease in tumour and peri-tumour acidoCEST value (Figure 2c and 2d)
after glucose injection were observed. Significant correlations were found
between baseline tumour AACID and peri-tumour acidoCEST (ρ = -0.79, P = 0.004);
tumour and peri-tumour ∆AACID (ρ = 0.78, P = 0.005); and tumour ∆AACID and
peri-tumour ∆acidoCEST (ρ = 0.65, P = 0.03) as shown in Figure 3b. Tumour
glycolysis measurement of Ki is significantly correlated with
∆acidoCEST (ρ = -0.68, P = 0.02) as shown in Figure 3a. No significant correlation was found between Ki
and AACID values at the tumour (ρ = -0.53, P = 0.09) and peri-tumour (ρ =
-0.54, P = 0.09) regions. Disscussion
The AACID value is inversely proportional to pHi
[4], whereas the acidoCEST value is directly proportional to pHe [5].
Glucose-induced changes in tumour and peri-tumour pHi and pHe
were detected using CEST, and tumour ∆AACID was directly proportional with both peri-tumour ∆AACID and
∆acidoCEST. This suggests that the glucose injection affects both tumour and
peri-tumour pHi consistently and changes in pHi
accordingly, whereas tumour pHi and peri-tumour pHe are
regulated in reverse. An
inversely proportional relationship was demonstrated between Ki and
tumour ∆acidoCEST. This suggests that higher tumour glycolytic activity would
lead to a decrease in tumour pHe, which agrees with a similar study
by Longo et al. [6]. Baseline tumour
AACID and peritumour acidoCEST displayed an inversely proportional relationship
(higher AACID value, lower pHi), that is associated with lower
peri-tumour acidoCEST value or pHe. Currently, precise pH
conversion between AACID and acidoCEST values, and information about the pH gradient across the intra- and
extracellular space is missing – this will be evaluated in the future with additional
calibration measurements and modeling. Conclusion
This
study demonstrated the capability of simultaneous measurements of pHi and
pHe using CEST MRI and provided a more complete picture of tumour pH
environment. Ki demonstrated the intrinsic relationship between
tumour glycolysis with tumour pHe. Acknowledgements
Natural Sciences and Engineering Research Council.
Government of Ontario.
Lawson Health Research Institute.
Department of Molecular Imaging, Western University.
References
[1] Wen PY, Kesari S. Malignant gliomas in
adults. N Engl J Med. 2008; 359:
492–507.
[2] Warburg O, Über den
Stoffwechsel der Carcinomzelle. Klinische Wochenschrift, 1925; 4:
534–536.
[3] Volk T, Jähde E,
Fortmeyer HP, Glüsenkamp KH and Rajewsky MF. pH in human tumour xenografts:
effect of intravenous administration of glucose. Br. J. Cancer, 1993; 68:
492-500.
[4] McVicar N, Li AX, Gonçalves
DF, Bellyou M, Meakin SO, Prado MAM, Bartha R. Quatatitive Tissue pH
Measurement during Cerebral Ischemia using Amine and Amide concentration-independent
Detection (AACID) with MRI. NMR Biomed 2015; 28:566
–575.
[5] Chen LQ, Howison CM,
Jeffery JJ, Robey IF, Kuo PH, Pagel MD, Evaluation of Extracellular pH within in
vivo Tumours using acidoCEST MRI, Magn. Reson. Med., 2014; 72:
1408-1417.
[6] Longo DL, Bartoli A, Consolino L, Bardini P,
Arena F, Schwaiger M, Aime S. In vivo imaging of tumor metabolism and
acidosis by combing PET and MRI-CEST pH imaging, Cancer Res. 2016; 76(22):
6463-6470.